Related Experiment Video
Updated: Aug 5, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
The impact of the COVID-19 pandemic on SLE
Xingwang Zhao1, Haohao Wu1, Shifei Li1
1Department of Dermatology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Insights
Systemic lupus erythematosus (SLE) patients faced many COVID-19 concerns. This review highlights shared inflammatory pathways, risks, and treatment options for SLE patients during the pandemic.
Area of Science:
- Immunology
- Rheumatology
- Infectious Diseases
Background:
- The association between coronavirus disease 2019 (COVID-19) and autoimmune diseases, particularly systemic lupus erythematosus (SLE), remains incompletely understood.
- SLE patients encountered numerous challenges during the COVID-19 pandemic, including infection risk, disease management, and vaccination decisions.
- Shared inflammatory pathways and immuno-inflammatory responses exist between SLE and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Approach:
- A comprehensive literature review was conducted to explore the multifaceted effects of the COVID-19 pandemic on patients with SLE.
- The review discusses clinical characteristics, pathological features, and cytokine profiles relevant to both SLE and SARS-CoV-2 infection.
- Epidemiological data, therapeutic strategies, and vaccination efficacy for SLE patients during the pandemic are analyzed.
Key Points:
- Current data are insufficient to fully assess COVID-19 risk and severity in SLE patients.
- Hydroxychloroquine and chloroquine are ineffective for COVID-19 prevention.
- SLE patients experienced higher hospitalization rates during the pandemic; vaccination is recommended to mitigate infection risk.
Conclusions:
- SARS-CoV-2 infection shares clinical and immunological similarities with SLE, necessitating careful management.
- Vaccination is crucial for reducing infection risk in SLE patients.
- This review provides valuable insights into the diagnosis, treatment, and prevention of COVID-19 in SLE patients.
Abstract:
Little is known about the association between coronavirus disease 2019 (COVID-19) and autoimmune diseases, especially in the case of systemic lupus erythematosus (SLE). SLE patients met with many questions during the pandemic in COVID-19, such as how to minimize risk of infection, the complex pathological features and cytokine profiles, diagnosis and treatment, rational choice of drugs and vaccine, good nursing, psychological supervision, and so on. In this study, we review and discuss the multifaceted effects of the COVID-19 pandemic on patients living with SLE using the available literature. Cross-talk in implicated inflammatory pathways/mechanisms exists between SLE and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and SARS-CoV-2 displays similar clinical characteristics and immuno-inflammatory responses to SLE. Current epidemiological data inadequately assess the risk and severity of COVID-19 infection in patients with SLE. More evidence has shown that hydroxychloroquine and chloroquine cannot prevent COVID-19. During the pandemic, patients with SLE had a higher rate of hospitalization. Vaccination helps to reduce the risk of infection. Several therapies for patients with SLE infected with COVID-19 are discussed. The cases in the study can provide meaningful information for clinical diagnosis and management. Our main aim is to help preventing infection and highlight treatment options for patients with SLE infected with COVID-19.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

